Published February 9, 2017
Role of the Drug Development Core in the UB Clinical and Translational Science Institute
The main objective of the University at Buffalo Clinical and Translational Science Institute (CTSI) Drug Development core is to foster innovation in drug development and clinical therapeutics research. While providing expert mentoring for researchers from the Buffalo Translational Consortium, the core also collaborates with industry partners, arranges access to CTSI core laboratory facilities that specialize in drug development, and helps investigators to prepare a top-flight grant application or cutting-edge research protocol.
Drug Development Core Director Gene D. Morse, PharmD, FCCP, BCPS, SUNY Distinguished Professor in the UB School of Pharmacy and Pharmaceutical Sciences Department of Pharmacy Practice, will present an overview outlining some of the services and resources the core provides to investigators on Wednesday, February 22, 12 - 1 p.m., in 339 Cary Hall, South Campus, UB.
Contact Shaweta Gupta, PhD by email or 716-829-6268 for more information.